# enGene Therapeutics Inc.: Form 10-K/A for the period ended Oct 31, 2025

- Company: [enGene Therapeutics Inc.](/companies/engn.md) (CIK 1980845)
- Form: 10-K/A
- Filed: 2026-02-19
- Accepted by EDGAR: Feb 19, 2026, 16:15 ET
- Period: 2025-10-31
- Accession: 0001193125-26-059409
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1980845/000119312526059409/engn-20251031.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1980845/000119312526059409/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1980845/000119312526059409/engn-20251031.htm

Filed Feb 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-059409. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.